| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
5,752,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile GlobeImmune is a biopharmaceutical company focused on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen® platform. Co. has three Tarmogen product candidates in clinical evaluation for infectious disease and multiple cancer indications. Co.'s infectious disease product candidates are: GS-4774 for hepatitis B infection; GI-19000 for tuberculosis; GI-2010 for human immunodeficiency virus; and GI-18000 for hepatitis D infection. Co.'s oncology product candidates are: GI-6207 for medullary thyroid cancer; GI-6301 for chordoma; and GI-4000 for resected pancreas cancer, non-small cell lung cancer, and colorectal cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mitchell Daniel J |
Director |
– • – |
2016-02-05 |
4 |
S |
$2.28 |
$2,962 |
I/I |
(1,300) |
6,926 |
|
- |
|
| Rodell Timothy C Jr |
CEO & PresOfficer |
• • – |
2015-04-10 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
1,904 |
|
- |
|
| Christoffersen Kirk A |
VP, Corporate Development |
• – – |
2014-12-15 |
4 |
OE |
$4.73 |
$11,300 |
D/D |
2,389 |
2,389 |
|
- |
|
| Mitchell Daniel J |
Director |
– • – |
2014-07-08 |
4 |
B |
$10.00 |
$100,000 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Mitchell Daniel J |
Director |
– • – |
2014-07-08 |
4 |
B |
$10.00 |
$750,000 |
I/I |
75,000 |
325,645 |
2.1 |
- |
|
| Mitchell Daniel J |
Director |
– • – |
2014-07-08 |
4 |
A |
$0.00 |
$0 |
I/I |
257,606 |
250,645 |
|
- |
|
| Rodell Timothy C Jr |
CEO & Pres |
• • – |
2014-07-08 |
4 |
B |
$10.00 |
$50,000 |
D/D |
5,000 |
5,000 |
2.81 |
- |
|
| Torres S. Edward |
Director |
– • – |
2014-07-08 |
4 |
B |
$10.00 |
$850,000 |
I/I |
85,000 |
267,894 |
2.1 |
- |
|
| Torres S. Edward |
Director |
– • – |
2014-07-08 |
4 |
A |
$0.00 |
$0 |
I/I |
182,894 |
182,894 |
|
- |
|
| Morgenthaler Management Partners Vii, Llc |
10% Owner |
– – • |
2014-07-08 |
4 |
B |
$10.00 |
$1,300,000 |
D/D |
130,000 |
530,461 |
2.45 |
- |
|
| Morgenthaler Management Partners Vii, Llc |
10% Owner |
– – • |
2014-07-08 |
4 |
A |
$0.00 |
$0 |
D/D |
400,461 |
400,461 |
|
- |
|
| Werner Harold R |
10% Owner |
– – • |
2014-07-08 |
4 |
B |
$10.00 |
$1,900,000 |
I/I |
190,000 |
584,267 |
1.5 |
- |
|
| Werner Harold R |
10% Owner |
– – • |
2014-07-08 |
4 |
A |
$0.00 |
$0 |
I/I |
394,267 |
394,267 |
|
- |
|
| Celgene Corp /de/ |
10% Owner |
– – • |
2014-07-08 |
4 |
B |
$10.00 |
$2,000,000 |
I/I |
200,000 |
600,670 |
1.5 |
- |
|
| Celgene Corp /de/ |
10% Owner |
– – • |
2014-07-08 |
4 |
A |
$0.00 |
$0 |
D/D |
400,670 |
400,670 |
|
- |
|
| Rodell Timothy C Jr |
CEO & PresOfficer |
• • – |
2014-07-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,094 |
|
- |
|
66 Records found
|
|
Page 3 of 3 |
|
|
